To make sure the studies were relevant, they needed to report at least one cardiovascular outcome, such as cardiovascular death, hospitalizations for heart failure, changes in heart structure or function, levels of heart biomarkers like N-terminal pro-B-type natriuretic peptide (NT-proBNP), or assessments of physical ability like the 6-minute walk test. Here, NPPB is linked to heart failure.